Provided by Tiger Trade Technology Pte. Ltd.

Cadrenal Therapeutics, Inc.

5.54
+0.11502.12%
Volume:7.87K
Turnover:43.86K
Market Cap:12.94M
PE:-0.68
High:5.68
Open:5.42
Low:5.42
Close:5.42
52wk High:22.90
52wk Low:5.34
Shares:2.34M
Float Shares:1.81M
Volume Ratio:0.35
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.1896
EPS(LYR):-8.7339
ROE:-468.03%
ROA:-209.23%
PB:4.73
PE(LYR):-0.63

Loading ...

Dec 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 23, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Dec 01, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities